132 related articles for article (PubMed ID: 10333248)
1. Comparison between the clonogenic, MTT, and SRB assays for determining radiosensitivity in a panel of human bladder cancer cell lines and a ureteral cell line.
Banasiak D; Barnetson AR; Odell RA; Mameghan H; Russell PJ
Radiat Oncol Investig; 1999; 7(2):77-85. PubMed ID: 10333248
[TBL] [Abstract][Full Text] [Related]
2. Comparison of sulforhodamine B, tetrazolium and clonogenic assays for in vitro radiosensitivity testing in human ovarian cell lines.
Griffon G; Merlin JL; Marchal C
Anticancer Drugs; 1995 Feb; 6(1):115-23. PubMed ID: 7538827
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of in vitro radiosensitivity in human bladder cancer cells.
Barnetson AR; Banasiak D; Fisher RJ; Mameghan H; Ribeiro JC; Brown K; Brown JL; O'Mara SM; Russell PJ
Radiat Oncol Investig; 1999; 7(2):66-76. PubMed ID: 10333247
[TBL] [Abstract][Full Text] [Related]
4. Measurement of radiation survival using the MTT assay.
Slavotinek A; McMillan TJ; Steel CM
Eur J Cancer; 1994; 30A(9):1376-82. PubMed ID: 7999428
[TBL] [Abstract][Full Text] [Related]
5. A comparison of clonogenic, microtetrazolium and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell lines.
Perez RP; Godwin AK; Handel LM; Hamilton TC
Eur J Cancer; 1993; 29A(3):395-9. PubMed ID: 8398340
[TBL] [Abstract][Full Text] [Related]
6. Use of the tetrazolium assay in measuring the response of human tumor cells to ionizing radiation.
Price P; McMillan TJ
Cancer Res; 1990 Mar; 50(5):1392-6. PubMed ID: 2302704
[TBL] [Abstract][Full Text] [Related]
7. Chemosensitivity and radiosensitivity of small cell lung cancer cell lines studied by a newly developed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) hybrid assay.
Hida T; Ueda R; Takahashi T; Watanabe H; Kato T; Suyama M; Sugiura T; Ariyoshi Y; Takahashi T
Cancer Res; 1989 Sep; 49(17):4785-90. PubMed ID: 2547517
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing.
Keepers YP; Pizao PE; Peters GJ; van Ark-Otte J; Winograd B; Pinedo HM
Eur J Cancer; 1991; 27(7):897-900. PubMed ID: 1834124
[TBL] [Abstract][Full Text] [Related]
9. [In vitro effects of piracetam on the radiosensitivity of hypoxic cells (adaptation of MTT assay to hypoxic conditions)].
Lagarde P; Gheuens EE; De Pooter CM; De Bruijn EA; van der Heyden S; Chomy F; Van Oosterom AT; Scalliet PG
Bull Cancer; 1995 Nov; 82(11):929-38. PubMed ID: 8535019
[TBL] [Abstract][Full Text] [Related]
10. Limitations of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays.
van Tonder A; Joubert AM; Cromarty AD
BMC Res Notes; 2015 Feb; 8():47. PubMed ID: 25884200
[TBL] [Abstract][Full Text] [Related]
11. Assay of anticancer drugs in tissue culture: comparison of a tetrazolium-based assay and a protein binding dye assay in short-term cultures derived from human malignant glioma.
Haselsberger K; Peterson DC; Thomas DG; Darling JL
Anticancer Drugs; 1996 May; 7(3):331-8. PubMed ID: 8792008
[TBL] [Abstract][Full Text] [Related]
12. [Usefulness of micronucleus assay in radiosensitivity tests using human cancer cell lines].
Kimura H
Nihon Hinyokika Gakkai Zasshi; 1998 Aug; 89(8):712-20. PubMed ID: 9780656
[TBL] [Abstract][Full Text] [Related]
13. MTT-hybrid assay incorporates the advantages of both clonogenic and MTT assay radiosensitivity testing for fresh tumor samples.
Enomoto T; Takao S; Mure H; Baba M; Aikou T
J Exp Clin Cancer Res; 1997 Sep; 16(3):273-80. PubMed ID: 9387901
[TBL] [Abstract][Full Text] [Related]
14. Potential use of the alkaline comet assay as a predictor of bladder tumour response to radiation.
McKeown SR; Robson T; Price ME; Ho ET; Hirst DG; McKelvey-Martin VJ
Br J Cancer; 2003 Dec; 89(12):2264-70. PubMed ID: 14676804
[TBL] [Abstract][Full Text] [Related]
15. Radiation sensitivity of Merkel cell carcinoma cell lines.
Leonard JH; Ramsay JR; Kearsley JH; Birrell GW
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1401-7. PubMed ID: 7635780
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two colorimetric assays as cytotoxicity endpoints for an in vitro screen for antitumour agents.
Fricker SP; Buckley RG
Anticancer Res; 1996; 16(6B):3755-60. PubMed ID: 9042253
[TBL] [Abstract][Full Text] [Related]
17. Radiosensitivity of new and established human melanoma cell lines: comparison of [3H]thymidine incorporation and soft agar clonogenic assays.
Marshall ES; Matthews JH; Shaw JH; Nixon J; Tumewu P; Finlay GJ; Holdaway KM; Baguley BC
Eur J Cancer; 1994; 30A(9):1370-6. PubMed ID: 7999427
[TBL] [Abstract][Full Text] [Related]
18. Not all 2 Gray radiation prescriptions are equivalent: Cytotoxic effect depends on delivery sequences of partial fractionated doses.
Lin PS; Wu A
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):536-44. PubMed ID: 16168846
[TBL] [Abstract][Full Text] [Related]
19. Robustness of Clonogenic Assays as a Biomarker for Cancer Cell Radiosensitivity.
Matsui T; Nuryadi E; Komatsu S; Hirota Y; Shibata A; Oike T; Nakano T
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450688
[TBL] [Abstract][Full Text] [Related]
20. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines.
Rubinstein LV; Shoemaker RH; Paull KD; Simon RM; Tosini S; Skehan P; Scudiero DA; Monks A; Boyd MR
J Natl Cancer Inst; 1990 Jul; 82(13):1113-8. PubMed ID: 2359137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
